NASDAQ:EIGR
Delisted

Eiger Biopharmaceuticals Stock News

etoro logo Buy EIGR
*Your capital is at risk
$1.73
+0 (+0%)
At Close: Aug 27, 2024
Two Sigma Advisers LP grew its stake in Eiger Biopharmaceuticals Inc (NASDAQ:EIGR) by 216.2% in the first quarter, according to the company in its most recent filing with the Securities and Exchange C
After Canaccord Genuity and Needham gave Rhythm Pharmaceuticals (NASDAQ: RYTM) a Buy rating last month, the company received another Buy,
In a report released today, Michael Higgins from Ladenburg Thalmann & Co. maintained a Buy rating on Marinus (MRNS –
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Achieve Life Sciences (ACHV –
Eiger BioPharmaceuticals (EIGR) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Two Sigma Investments LP grew its holdings in shares of Eiger Biopharmaceuticals Inc (NASDAQ:EIGR) by 112.6% in the first quarter, according to its most recent filing with the Securities and Exchange
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Xenetic Biosciences
In a report issued on June 12, Liana Moussatos from Wedbush maintained a Buy rating on Aquestive Therapeutics (AQST –
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F
Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR) announced today that, due to public health and safety concerns related to the COVID-19 global pandemic, recommendations and orders from federal, state and
Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that Eiger management wil
May 25, 2020 (CDN Newswire via Comtex) -- Global Dilated Cardiomyopathy Therapeutic Market 2020 by Company, Regions, Type and Application, Forecast to 2026...
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 19) * ADC Therapeutics SA (NYSE: ADCT) (IPOed May 15) * A
Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that the U.S. Food and Dr
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE